KLRS (STOCKS)

    Kalaris Therapeutics, Inc. Common Stock

    $5.950000
    +0.130000 (+2.23%)
    Prev close: $5.820000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Andrew Oxtoby
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $134.13M
    Employees
    20
    P/E (TTM)
    -1.40
    P/B (TTM)
    1.71
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.